Roche Unveils AI-Enabled Predictive CGM Solution for Diabetes Care in the Middle East

Roche’s Accu-Chek SmartGuide leverages artificial intelligence to predict glucose trends over 30 minutes, 2 hours, and overnight, offering patients reliable guidance to improve self-care, reduce emotional stress, and support adherence to therapy.

Roche Diagnostics Middle East has launched the Accu-Chek SmartGuide, an AI-enabled continuous glucose monitoring system, marking a major advancement in diabetes management by predicting glucose fluctuations up to 30 minutes in advance.

Dr Hussain Abdul Rahman Al Rand, Assistant Undersecretary for the Public Health Sector, UAE, said, “Innovation in healthcare is not just about technology. It is about improving lives, preventing disease, and building a healthier and more resilient nation for future generations through partnership and evidence-based practice.”

The Middle East faces one of the highest prevalence rates of diabetes globally, with over 1.3 million adults living with the condition in the UAE alone. Diabetes contributes significantly to secondary health complications such as cardiovascular disease, kidney and nerve damage, blindness, and mental health challenges.

Roche’s Accu-Chek SmartGuide leverages artificial intelligence to predict glucose trends over 30 minutes, 2 hours, and overnight, offering patients reliable guidance to improve self-care, reduce emotional stress, and support adherence to therapy.

Already available in Kuwait, Saudi Arabia, and Qatar, the technology aims to empower individuals with diabetes to lead healthier, more confident lives.

This launch reflects Roche’s ongoing commitment to digital health innovation, combining advanced AI algorithms with patient-centred design. By providing anticipatory insights, the solution helps bridge gaps in traditional diabetes management and addresses urgent regional healthcare needs.

With continuous monitoring, real-time alerts, and predictive capabilities, the Accu-Chek SmartGuide sets a new standard of care for the region. The technology reinforces global trends where AI-driven medical devices increasingly support personalized treatment and proactive disease management.

Stay tuned for more such updates on Digital Health News